M ost patients with insulin-dependent diabetes mellitus (IDDM) of recent onset have circulating antibodies against pancreatic islet cells (ICAs; 1-3). These antibodies bind to all endocrine cells in the islets of Langerhans and are usually detected by indirect immunofluorescence staining of sections of human pancreas (1-3). Insulin-producing p-cells, other endocrine cells of the pancreas, and neuroendocrine tumors are of the same embryological origin (4). Therefore, we examined whether tumors of neuroendocrine origin would express antigens similar to those in pancreatic islet cells. We report that From the
M ost patients with insulin-dependent diabetes mellitus (IDDM) of recent onset have circulating antibodies against pancreatic islet cells (ICAs; 1-3). These antibodies bind to all endocrine cells in the islets of Langerhans and are usually detected by indirect immunofluorescence staining of sections of human pancreas (1) (2) (3) . Insulin-producing p-cells, other endocrine cells of the pancreas, and neuroendocrine tumors are of the same embryological origin (4) . Therefore, we examined whether tumors of neuroendocrine origin would express antigens similar to those in pancreatic islet cells. We report that most ICA + serums react with frozen sections of gastrointestinal carcinoid tumors and that most patients with recentonset IDDM have serum antibodies that bind not only to pancreatic islet cells but also to carcinoid tumors, especially those from the gastrointestinal tract.
MATERIALS AND METHODS
The serums tested were the provisional Juvenile Diabetes Foundation (JDF) ICA + reference serum containing 80 JDF units of ICA per milliliter (5) and ICA serums from routine ICA determinations at the Department of Bacteriology and Immunology (Univ. of Helsinki). Serum samples from 48 children with newly diagnosed IDDM, obtained within 2 wk of diagnosis, were also tested. The children were treated at the Department of Pediatrics (Aurora Hospital, Helsinki). Informed consent was obtained from the children and/or the parents. The study was approved by the ethics committee at the Aurora Hospital. All serums were aliquoted and stored at -20°C until use.
We used human pancreas tissue (from a patient with group 0 blood) in the routine assays for ICA, three gastrointestinal carcinoid tumors, and a panel of other tumors of neuroendocrine origin. The tumors were removed during surgery and sent for histopathologic diagnosis to the Department of Pathology. All tissues were snap frozen in liquid nitrogencooled isopentane and stored at -70°C until use in the antibody assays.
Unfixed frozen 5-fjun-thick sections of tumor or pancreatic tissues were incubated with patient or control serums (undiluted or diluted in phosphate-buffered saline [PBS]), washed in PBS, and further incubated with fluorescein isothiocyanate (FITC)-labeled rabbit anti-human IgG (7-chain specific; Behringwerke, Marburg, FRG) (6). After washes with PBS, the slides were mounted for immunofluorescence microscopy. A Zeiss standard fluorescence microscope equipped with epi-illumination and interference filters for FITC was used as described (7) . For ICA determinations, all serums were tested both undiluted and diluted 1:10, and the positive serums were further tested in serial twofold di-lutions. For carcinoid antibodies, the serums were tested undiluted. Some of the positive serums were further tested in serial twofold dilutions. The titers of the serums refer to the last dilutions giving a positive fluorescence. All fluorescence microscopy was done blindly by two independent viewers (A.M. and H.H.). The correlation between the two viewers was 1.0 for the ICA and 0.95 for the antibodies against carcinoids in initial screening. Occasional serums (12 of 183 serums studied [7%]) were excluded from the study because of other disturbing autoantibodies (e.g., antinuclear antibodies). The criteria for ICA positivity were as described by Bottazzo et al. (1) and Marner et al. (8) . A sample was considered ICA + if the cytoplasm of all endocrine cells in most islets in a section showed fluorescence when viewed at a magnification of x240 (Fig. 16) . Similarly, a sample was considered positive for carcinoid antibodies if the cytoplasm of the carcinoid cells in most tumor lobules showed fluorescence ( Fig. 1/\) . If the islet or carcinoid cell fluorescence could not be distinguished from fluorescence in the exocrine or stromal tissues, the samples were considered ICA- 
RESULTS
All but one of the known ICA + serums initially screened bound to frozen sections of gastrointestinal carcinoid tumors, as did one of the ICA~ control serums ( Table 1 ). The JDF ICA + reference serum reacted with the carcinoid tumors tested. The JDF reference serum and the ICA + serums with antibodies binding to carcinoid tumors gave a homogenous cytoplasmic staining of the carcinoid cells (Fig. 1) . The staining was most intense toward the peripheral parts of the carcinoid cell lobules. The titer of the JDF reference serum on the pancreatic tissue was 1:32, whereas its titer on the gastrointestinal carcinoid tumors was 1:8. Most of the ICA + serums tested had lower titers on gastrointestinal carcinoids than on pancreatic tissue, but some serums had equal titers on both tissues. About half of the ICA + serums also reacted against a panel of other neuroendocrine tumors, including four pheochromocytomas, one bronchial carcinoid, and one primary and two metastatic thyroid medullary carcinomas (data not shown).
Twenty-four of the 25 other ICA + adult serums (96%) from the routine testing also reacted with the gastrointestinal carcinoid tumor used for further analysis (tumor 3, Table 1 ). Forty of the 50 (80%) adult control serums were ICA" and did not react with the carcinoid tissue. Two (4%) were ICA + but did not stain the tumor cells, and 8 (16%) were ICA~ but reacted with carcinoid cells (Table 2) .
Forty (83%) of the 48 serums from children with recentonset IDDM had ICAs, and 36 (75%) also had antibodies binding to carcinoid tumor (Table 2) . Thirty-five (73%) of the serums stained both pancreatic islet and carcinoid tumor cells in comparable dilutions. Seven serums (7 of 48; 15%) did not stain pancreatic islet or carcinoid cells, 5 (10%) stained pancreatic islet but not carcinoid cells, and 1 stained carcinoid but not pancreatic islet cells. None of the 34 control serums from nondiabetic children reacted with pancreatic islet cells, but 2 (6%) reacted with the carcinoid cells.
DISCUSSION
The cytoplasmic and membrane-bound antigens of pancreatic endocrine cells recognized by ICA are poorly characterized (3, 9) . The common embryological derivation of endocrine cells in islets of Langerhans and tumors derived from neuroendocrine cells, such as gastrointestinal carcinoids (4), prompted us to search for ICA-reactive antigenic determinants expressed on these tissues. JDF reference serum, 95% of the ICA + serums, and 75% (as opposed to 83% reacting with islet cells) of the serums of children with newly diagnosed IDDM also reacted with gastrointestinal (6) 73 (92) 10 (12) Values in parentheses are percentages. *Tumor 3 from Table 1 . fSerums selected from routine ICA determinations, including those from Table 1 . tNone of the serums reacted with bovine adrenal medulla. §Normal adults and 19 patients with reactive arthritis. USerums taken within 2 wk of diagnosis from children with newly diagnosed IDDM. Children with minor elective surgery or psychosomatic disorders.
carcinoid tumors. In normal control subjects (adults), reactivity against islet cells was found in 4%, and reactivity 
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